Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma

Head and Neck

Volumn 18, Issue 4, 1996, Pages 335-342

  Kerrebijn, Jeroen D ^a,b,c   Simons, Peter J ^b,c   Balm, Alfonsus J M ^g   Tas, Maarten ^d   Knegt, Paul P ^a   De Vries, Nico ^e   Tan, Ing B ^f   Drexhage, Hemmo A ^b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MEDICAL CENTER HAAGLANDEN   (Netherlands)

^g University Hospital Dijkzigt ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; THYMOSTIMULIN;

ARTICLE; CANCER IMMUNOTHERAPY; CHEMOTAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEAD AND NECK CANCER; HUMAN; IMMUNOMODULATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MONOCYTE; MULTICENTER STUDY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0029948493     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199607/08)18:4<335::aid-hed4>3.0.co;2-z     Document Type: Article

References (32)

1. Lapointe H, Lampe H, Banerjee D. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses. Otolaryngolog Head Neck Surg 1992;106:149-158.
2. Vlock DR. Immunobiologic aspects of head and neck cancer. Hematol Oncol Clin N Am 1991;5:797-820.
3. Balm AJM, Drexhage HA, Von Blomberg ME, Snow GB. Mononuclear phagocyte function in head and neck cancer: NBT-DYE reduction, maturation and migration of peripheral blood monocytes. Laryngoscope 1982;92:810-814.
4. Balm AJM, Drexhage HA, Von Blomberg M, Weltevreden EF, Veldhuizen RW, Mullink R, Snow GB. Mononuclear phagocyte function in head and neck cancer: chemotactic responsiveness of blood monocytes in correlation between histologic grade of the tumor and infiltration of these cells into the tumor area. Cancer 1984;54:1010-1015.
5. Cameron DJ, Stromberg BV. The ability of macrophages from head and neck cancer patients to kill tumor cells. Cancer 1984;54:2403-2408.
6. Garraud O, Faucher A, Legrand E. Impairment of monocyte functions in advanced head and neck cancer. Immunol Lett 1988;18:213-218.
7. Gungor A, Yetgin S, Sozeri B. Defective monocyte chemotaxis in patients with epidermoid tumors of the head and neck. Eur Arch Otorhinolaryngol 1993;250:289-291.
8. Tan IB, Drexhage HA, Scheper RJ, et al. Defective monocyte chemotaxis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1986;112:541-544.
9. Tas MP, Simons PJ, Balm AJM, Drexhage HA. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones. Cancer Immunol Immunother 1993;36:108-114.
10. Kerrebijn JD, Simons PJ, Tas M, Balm AJM, Drexhage HA. In vivo effects of TP1 treatment on monocyte polarization, dendritic cell clustering and serum p15E-like TM factors in operable head and neck squamous cell carcinoma patients Eur Arch Otorhinolaryngol 1995;252:409-416.
11. Simons PJ, Oostendorp RAJ, Tas MPR, Drexhage HA Comparison of retroviral p15E-related factors and inter-feron alpha in head and neck cancer. Cancer Immunol Immunother 1994;38:178-184.
12. Tan IB (1986) Retroviral p15E related factors in head and neck cancer. Thesis, Vonk/Zeist, The Netherlands.
13. Bergesi G, Falchetti R. Chemical characterization and biological activity of a new thymic extract. Folia Allergol Immunol Clin 1977;21:204-208.
14. Falchetti R, Bergesi G, Eshkol A, Cafiero C, Adorini L, Caprino L. Pharmacological and biological properties of a calf thymus extract (TP-1). Drugs Exp Clin Res 1977;3:39-47.
15. Kabel PJ, de Haan-Meulman M, Voorbij HAM. Kleingeld M, Knol EF, Drexhage HA. Accessory cells with a morphology and marker patterns of dendritic cells can be obtained from elutriator-purified blood monocyte fractions. An enhancing effect of metrizamide in this differentiation. Immunobiol 1989;179:395-411.
16. Mooy P, Simons PJ, de Haan-Meulman M, de Wit HJ, Drexhage HA. Effect of thyroid hormones and other iodinated compounds on the transition of monocytes into veiled/dendritic cells: role of granulocyte-macrophage colony-stimulating factor, tumour-necrosis factor-α and interleukin-6. J Endocrinol 1994;140:503-508.
17. Kerrebijn JD, Balm AJM, Knegt PP, Meeuwis CA, Drexhage HA. Macrophage and dendritic cell in infiltration in head and neck squamous-cell carcinoma: an immunohistochemical study. Cancer Immunol Immunother 1994;38:31-37.
18. Horst HA, Horny HP. Tumor-infiltrating lymphoreticular cells. Histologic and immunohistologic investigations performed on metastasizing squamous cell carcinomas of the head and neck. Cancer 1991;68:2397-2402.
19. Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, Bondi R. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991;117:1007-1010.
20. Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T. Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 1986;57:100-105.
21. Furihata M, Ohtsuki Y, Ido E, et al. HLA-DR antigen- and S100 protein-positive dendritic cells in esophageal squamous cell carcinoma - their distribution in relation to prognosis. Virchows Archiv B Cell Pathol 1992;61:409-414.
22. Nakano T, Oka K, Aral T, Morita S, Tsunemoto H. Prognostic significance of Langerhans' cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med 1989;113:507-511.
23. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 1990;66:2012-2016.
24. Tsujitani S, Furukawa T, Tamada R, Okamura T, Yasumoto K, Sugimachi K. Langerhans cells and prognosis in patients with gastric carcinoma. Cancer 1987;59:501-505.
25. Giannini A, Bianchi S, Messerrini L, et al. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. Path Res Pract 1991;187:496-502.
26. Safer D, Elzinga M, Nachmias VT. Thymosin Beta 4 an Fx, an actin-sequestering peptide, are indistinguishable. J Biol chem 1991;266:4029-4032.
27. Drexhage HA, Mullink H, de Groot J, Clarke J, Balfour BM. A study of cells present in peripheral lymph of pigs with special reference to a type of cell resembling the Langerhans cell. Cell Tissue Res 1979;202:407-430.
28. Guo MN, Rabin BS, Johnson T, Paradis IL. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer. Head Neck Surg 1987;9:265-271.
29. Wolf GR, Hudson JL, Peterson KA, Miller HL, McClatchey KD. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Head Neck Surg 1986;95:142-152
30. Pastorfide GC, Kibbi AG, de Roa AL, Barnhill RL, Sober AJ, Mihm MC, Byers HR. Image analysis of stage 1 melanoma (1.00-2.50 mm): lymphocytic infiltrates related to metastasis and survival. J Cutan Pathol 1992;19:390-397.
31. Gallo O, Bianchi S, Giannini A, Gallina E, Libonati GA, Fini-Storchi O. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope 1991;101:487-493.
32. Stewart THM, Tsai SCJ. The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer. Clin Exp Metastasis 1993;11:295-305.